Skip to main content

Web Exclusives

The Dirty Dozen Redux

David B. Nash, MD, MBA

ESMO 2020 Highlights

Olaparib a New Option for Men with Metastatic Prostate Cancer and BRCA Mutation

Phoebe Starr

ESMO 2020 Highlights

Nivolumab New Standard of Care in Gastroesophageal Cancers as First-Line or Adjuvant Therapy

Phoebe Starr

David B. Nash, MD, MBA

Infectious Diseases

COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population

Phoebe Starr

Disparities in Cancer Care, Oncology

AACR’s Cancer Disparities Inaugural Report Addresses Care Inequities

Wayne Kuznar

Opdivo Approved for Advanced Esophageal Squamous-Cell Carcinoma

FDA Approvals, Lung Cancer, Oncology

FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation

FDA Approvals, Lung Cancer, Oncology

Opdivo plus Yervoy and Limited Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC, Regardless of PD-L1 Expression

FDA Approvals, Lung Cancer, Oncology

Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma

Page 15 of 37
Results 141 - 150 of 362